Cover Image

Mobocertinib in patients with EGFR Exon 20 insertion-positive non-small cell lung cancer (MOON): an international real-world safety and efficacy analysis

EGFR exon 20 (EGFR Ex20) insertion mutations in non-small cell lung cancer (NSCLC) are insensitive to traditional EGFR tyrosine kinase inhibitors (TKIs). Mobocertinib is the only approved TKI specifically designed to target EGFR Ex20. We performed an international, real-world safety and efficacy ana...

Full description

Saved in:
Bibliographic Details
Main Authors: Illini, Oliver (Author) , Saalfeld, Felix (Author) , Christopoulos, Petros (Author) , Duruisseaux, Michaël (Author) , Vikström, Anders (Author) , Peled, Nir (Author) , Demedts, Ingel (Author) , Dudnik, Elizabeth (Author) , Eisert, Anna (Author) , Hashemi, Sayed M. S. (Author) , Janzic, Urska (Author) , Kian, Waleed (Author) , Mohorcic, Katja (Author) , Mohammed, Saara (Author) , Silvoniemi, Maria (Author) , Rothschild, Sacha I. (Author) , Schulz, Christian (Author) , Wesseler, Claas (Author) , Addeo, Alfredo (Author) , Armster, Karin (Author) , Itchins, Malinda (Author) , Ivanović, Marija (Author) , Kauffmann-Guerrero, Diego (Author) , Koivunen, Jussi (Author) , Kuon, Jonas (Author) , Pavlakis, Nick (Author) , Piet, Berber (Author) , Sebastian, Martin (Author) , Velthaus-Rusik, Janna-Lisa (Author) , Wannesson, Luciano (Author) , Wiesweg, Marcel (Author) , Wurm, Robert (Author) , Albers-Leischner, Corinna (Author) , Aust, Daniela E. (Author) , Janning, Melanie (Author) , Fabikan, Hannah (Author) , Herold, Sylvia (Author) , Klimova, Anna (Author) , Loges, Sonja (Author) , Sharapova, Yana (Author) , Schütz, Maret (Author) , Weinlinger, Christoph (Author) , Valipour, Arschang (Author) , Overbeck, Tobias (Author) , Griesinger, Frank (Author) , Jakopovic, Marko (Author) , Hochmair, Maximilian (Author) , Wermke, Martin (Author)
Format: Article (Journal)
Language:English
Published: April 2024
In: International journal of molecular sciences
Year: 2024, Volume: 25, Issue: 7, Pages: 1-19
ISSN:1422-0067
DOI:10.3390/ijms25073992
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms25073992
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/25/7/3992
Get full text
Author Notes:Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos, Michaël Duruisseaux, Anders Vikström, Nir Peled, Ingel Demedts, Elizabeth Dudnik, Anna Eisert, Sayed M. S. Hashemi, Urska Janzic, Waleed Kian, Katja Mohorcic, Saara Mohammed, Maria Silvoniemi, Sacha I. Rothschild, Christian Schulz, Claas Wesseler, Alfredo Addeo, Karin Armster, Malinda Itchins, Marija Ivanović, Diego Kauffmann-Guerrero, Jussi Koivunen, Jonas Kuon, Nick Pavlakis, Berber Piet, Martin Sebastian, Janna-Lisa Velthaus-Rusik, Luciano Wannesson, Marcel Wiesweg, Robert Wurm, Corinna Albers-Leischner, Daniela E. Aust, Melanie Janning, Hannah Fabikan, Sylvia Herold, Anna Klimova, Sonja Loges, Yana Sharapova, Maret Schütz, Christoph Weinlinger, Arschang Valipour, Tobias Raphael Overbeck, Frank Griesinger, Marko Jakopovic, Maximilian J. Hochmair and Martin Wermke

MARC

LEADER 00000caa a2200000 c 4500
001 1906374899
003 DE-627
005 20241205182056.0
007 cr uuu---uuuuu
008 241022s2024 xx |||||o 00| ||eng c
024 7 |a 10.3390/ijms25073992  |2 doi 
035 |a (DE-627)1906374899 
035 |a (DE-599)KXP1906374899 
035 |a (OCoLC)1475316401 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Illini, Oliver  |e VerfasserIn  |0 (DE-588)1345689802  |0 (DE-627)1906375984  |4 aut 
245 1 0 |a Mobocertinib in patients with EGFR Exon 20 insertion-positive non-small cell lung cancer (MOON)  |b an international real-world safety and efficacy analysis  |c Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos, Michaël Duruisseaux, Anders Vikström, Nir Peled, Ingel Demedts, Elizabeth Dudnik, Anna Eisert, Sayed M. S. Hashemi, Urska Janzic, Waleed Kian, Katja Mohorcic, Saara Mohammed, Maria Silvoniemi, Sacha I. Rothschild, Christian Schulz, Claas Wesseler, Alfredo Addeo, Karin Armster, Malinda Itchins, Marija Ivanović, Diego Kauffmann-Guerrero, Jussi Koivunen, Jonas Kuon, Nick Pavlakis, Berber Piet, Martin Sebastian, Janna-Lisa Velthaus-Rusik, Luciano Wannesson, Marcel Wiesweg, Robert Wurm, Corinna Albers-Leischner, Daniela E. Aust, Melanie Janning, Hannah Fabikan, Sylvia Herold, Anna Klimova, Sonja Loges, Yana Sharapova, Maret Schütz, Christoph Weinlinger, Arschang Valipour, Tobias Raphael Overbeck, Frank Griesinger, Marko Jakopovic, Maximilian J. Hochmair and Martin Wermke 
246 1 |i Titel des special issue  |a Lung Cancers: an update on molecular diagnostics and therapy 
264 1 |c April 2024 
300 |b Illustrationen 
300 |a 19 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht am 3. April 2024 
500 |a Gesehen am 22.10.2024 
520 |a EGFR exon 20 (EGFR Ex20) insertion mutations in non-small cell lung cancer (NSCLC) are insensitive to traditional EGFR tyrosine kinase inhibitors (TKIs). Mobocertinib is the only approved TKI specifically designed to target EGFR Ex20. We performed an international, real-world safety and efficacy analysis on patients with EGFR Ex20-positive NSCLC enrolled in a mobocertinib early access program. We explored the mechanisms of resistance by analyzing postprogression biopsies, as well as cross-resistance to amivantamab. Data from 86 patients with a median age of 67 years and a median of two prior lines of treatment were analyzed. Treatment-related adverse events (TRAEs) occurred in 95% of patients. Grade ≥3 TRAEs were reported in 38% of patients and included diarrhea (22%) and rash (8%). In 17% of patients, therapy was permanently discontinued, and two patients died due to TRAEs. Women were seven times more likely to discontinue treatment than men. In the overall cohort, the objective response rate to mobocertinib was 34% (95% CI, 24-45). The response rate in treatment-naïve patients was 27% (95% CI, 8-58). The median progression-free and overall survival was 5 months (95% CI, 3.5-6.5) and 12 months (95% CI, 6.8-17.2), respectively. The intracranial response rate was limited (13%), and one-third of disease progression cases involved the brain. Mobocertinib also showed antitumor activity following EGFR Ex20-specific therapy and vice versa. Potential mechanisms of resistance to mobocertinib included amplifications in MET, PIK3CA, and NRAS. Mobocertinib demonstrated meaningful efficacy in a real-world setting but was associated with considerable gastrointestinal and cutaneous toxicity. 
650 4 |a EGFR exon 20 inhibitors 
650 4 |a exon 20 insertion 
650 4 |a mobocertinib 
650 4 |a non-small cell lung cancer 
650 4 |a real-world data 
700 1 |a Saalfeld, Felix  |e VerfasserIn  |0 (DE-588)1247741877  |0 (DE-627)1782344950  |4 aut 
700 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
700 1 |a Duruisseaux, Michaël  |e VerfasserIn  |4 aut 
700 1 |a Vikström, Anders  |e VerfasserIn  |4 aut 
700 1 |a Peled, Nir  |e VerfasserIn  |0 (DE-588)1225517001  |0 (DE-627)1745192115  |4 aut 
700 1 |a Demedts, Ingel  |e VerfasserIn  |4 aut 
700 1 |a Dudnik, Elizabeth  |e VerfasserIn  |4 aut 
700 1 |a Eisert, Anna  |e VerfasserIn  |4 aut 
700 1 |a Hashemi, Sayed M. S.  |e VerfasserIn  |4 aut 
700 1 |a Janzic, Urska  |e VerfasserIn  |4 aut 
700 1 |a Kian, Waleed  |e VerfasserIn  |0 (DE-588)1274752825  |0 (DE-627)1824503814  |4 aut 
700 1 |a Mohorcic, Katja  |e VerfasserIn  |4 aut 
700 1 |a Mohammed, Saara  |e VerfasserIn  |4 aut 
700 1 |a Silvoniemi, Maria  |e VerfasserIn  |4 aut 
700 1 |a Rothschild, Sacha I.  |e VerfasserIn  |4 aut 
700 1 |a Schulz, Christian  |e VerfasserIn  |4 aut 
700 1 |a Wesseler, Claas  |d 1979-  |e VerfasserIn  |0 (DE-588)137564600  |0 (DE-627)593660749  |0 (DE-576)304121029  |4 aut 
700 1 |a Addeo, Alfredo  |e VerfasserIn  |4 aut 
700 1 |a Armster, Karin  |e VerfasserIn  |4 aut 
700 1 |a Itchins, Malinda  |e VerfasserIn  |0 (DE-588)1296621812  |0 (DE-627)1853073733  |4 aut 
700 1 |a Ivanović, Marija  |e VerfasserIn  |4 aut 
700 1 |a Kauffmann-Guerrero, Diego  |d 1988-  |e VerfasserIn  |0 (DE-588)1299859895  |0 (DE-627)1857250826  |4 aut 
700 1 |a Koivunen, Jussi  |e VerfasserIn  |4 aut 
700 1 |a Kuon, Jonas  |e VerfasserIn  |0 (DE-588)1166909484  |0 (DE-627)1030803730  |0 (DE-576)510963129  |4 aut 
700 1 |a Pavlakis, Nick  |e VerfasserIn  |4 aut 
700 1 |a Piet, Berber  |e VerfasserIn  |4 aut 
700 1 |a Sebastian, Martin  |d 1965-  |e VerfasserIn  |0 (DE-588)129885916  |0 (DE-627)482779640  |0 (DE-576)297886975  |4 aut 
700 1 |a Velthaus-Rusik, Janna-Lisa  |e VerfasserIn  |4 aut 
700 1 |a Wannesson, Luciano  |e VerfasserIn  |4 aut 
700 1 |a Wiesweg, Marcel  |d 1984-  |e VerfasserIn  |0 (DE-588)1053769695  |0 (DE-627)790697696  |0 (DE-576)409703060  |4 aut 
700 1 |a Wurm, Robert  |e VerfasserIn  |4 aut 
700 1 |a Albers-Leischner, Corinna  |e VerfasserIn  |4 aut 
700 1 |a Aust, Daniela E.  |e VerfasserIn  |0 (DE-588)1043852360  |0 (DE-627)771001665  |0 (DE-576)174280815  |4 aut 
700 1 |a Janning, Melanie  |e VerfasserIn  |0 (DE-588)1254060979  |0 (DE-627)1796679704  |4 aut 
700 1 |a Fabikan, Hannah  |e VerfasserIn  |4 aut 
700 1 |a Herold, Sylvia  |e VerfasserIn  |4 aut 
700 1 |a Klimova, Anna  |e VerfasserIn  |4 aut 
700 1 |a Loges, Sonja  |d 1973-  |e VerfasserIn  |0 (DE-588)129285463  |0 (DE-627)480392161  |0 (DE-576)297579002  |4 aut 
700 1 |a Sharapova, Yana  |e VerfasserIn  |4 aut 
700 1 |a Schütz, Maret  |e VerfasserIn  |4 aut 
700 1 |a Weinlinger, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Valipour, Arschang  |e VerfasserIn  |0 (DE-588)1138951897  |0 (DE-627)896569888  |0 (DE-576)492793344  |4 aut 
700 1 |a Overbeck, Tobias  |d 1972-  |e VerfasserIn  |0 (DE-588)173585752  |0 (DE-627)69849623X  |0 (DE-576)13442946X  |4 aut 
700 1 |a Griesinger, Frank  |e VerfasserIn  |0 (DE-588)1080408916  |0 (DE-627)844436305  |0 (DE-576)453541747  |4 aut 
700 1 |a Jakopovic, Marko  |e VerfasserIn  |4 aut 
700 1 |a Hochmair, Maximilian  |e VerfasserIn  |0 (DE-588)119783236X  |0 (DE-627)1679746901  |4 aut 
700 1 |a Wermke, Martin  |d 1978-  |e VerfasserIn  |0 (DE-588)1143166787  |0 (DE-627)1002562465  |0 (DE-576)494958294  |4 aut 
773 0 8 |i Enthalten in  |t International journal of molecular sciences  |d Basel : Molecular Diversity Preservation International, 2000  |g 25(2024), 7, special issue vom: Apr., Artikel-ID 3992, Seite 1-19  |h Online-Ressource  |w (DE-627)316340715  |w (DE-600)2019364-6  |w (DE-576)281194653  |x 1422-0067  |7 nnas  |a Mobocertinib in patients with EGFR Exon 20 insertion-positive non-small cell lung cancer (MOON) an international real-world safety and efficacy analysis 
773 1 8 |g volume:25  |g year:2024  |g number:7  |g month:04  |g supplement:special issue  |g elocationid:3992  |g pages:1-19  |g extent:19  |a Mobocertinib in patients with EGFR Exon 20 insertion-positive non-small cell lung cancer (MOON) an international real-world safety and efficacy analysis 
856 4 0 |u https://doi.org/10.3390/ijms25073992  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1422-0067/25/7/3992  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241022 
993 |a Article 
994 |a 2024 
998 |g 129285463  |a Loges, Sonja  |m 129285463:Loges, Sonja  |d 60000  |d 63600  |e 60000PL129285463  |e 63600PL129285463  |k 0/60000/  |k 1/60000/63600/  |p 39 
998 |g 1254060979  |a Janning, Melanie  |m 1254060979:Janning, Melanie  |d 60000  |e 60000PJ1254060979  |k 0/60000/  |p 35 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |e 50000PC138659702  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 3 
999 |a KXP-PPN1906374899  |e 4600729404 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"titleAlt":[{"title":"Lung Cancers: an update on molecular diagnostics and therapy"}],"note":["Online veröffentlicht am 3. April 2024","Gesehen am 22.10.2024"],"recId":"1906374899","physDesc":[{"extent":"19 S.","noteIll":"Illustrationen"}],"relHost":[{"note":["Gesehen am 17.09.20"],"recId":"316340715","physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"IJMS"}],"language":["eng"],"pubHistory":["1.2000 -"],"title":[{"title_sort":"International journal of molecular sciences","title":"International journal of molecular sciences"}],"disp":"Mobocertinib in patients with EGFR Exon 20 insertion-positive non-small cell lung cancer (MOON) an international real-world safety and efficacy analysisInternational journal of molecular sciences","origin":[{"publisherPlace":"Basel","dateIssuedKey":"2000","publisher":"Molecular Diversity Preservation International","dateIssuedDisp":"2000-"}],"part":{"volume":"25","extent":"19","issue":"7","pages":"1-19","text":"25(2024), 7, special issue vom: Apr., Artikel-ID 3992, Seite 1-19","year":"2024"},"id":{"zdb":["2019364-6"],"eki":["316340715"],"issn":["1422-0067","1661-6596"]}}],"title":[{"subtitle":"an international real-world safety and efficacy analysis","title":"Mobocertinib in patients with EGFR Exon 20 insertion-positive non-small cell lung cancer (MOON)","title_sort":"Mobocertinib in patients with EGFR Exon 20 insertion-positive non-small cell lung cancer (MOON)"}],"name":{"displayForm":["Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos, Michaël Duruisseaux, Anders Vikström, Nir Peled, Ingel Demedts, Elizabeth Dudnik, Anna Eisert, Sayed M. S. Hashemi, Urska Janzic, Waleed Kian, Katja Mohorcic, Saara Mohammed, Maria Silvoniemi, Sacha I. Rothschild, Christian Schulz, Claas Wesseler, Alfredo Addeo, Karin Armster, Malinda Itchins, Marija Ivanović, Diego Kauffmann-Guerrero, Jussi Koivunen, Jonas Kuon, Nick Pavlakis, Berber Piet, Martin Sebastian, Janna-Lisa Velthaus-Rusik, Luciano Wannesson, Marcel Wiesweg, Robert Wurm, Corinna Albers-Leischner, Daniela E. Aust, Melanie Janning, Hannah Fabikan, Sylvia Herold, Anna Klimova, Sonja Loges, Yana Sharapova, Maret Schütz, Christoph Weinlinger, Arschang Valipour, Tobias Raphael Overbeck, Frank Griesinger, Marko Jakopovic, Maximilian J. Hochmair and Martin Wermke"]},"person":[{"given":"Oliver","role":"aut","display":"Illini, Oliver","family":"Illini"},{"given":"Felix","display":"Saalfeld, Felix","role":"aut","family":"Saalfeld"},{"given":"Petros","display":"Christopoulos, Petros","role":"aut","family":"Christopoulos"},{"given":"Michaël","family":"Duruisseaux","role":"aut","display":"Duruisseaux, Michaël"},{"family":"Vikström","display":"Vikström, Anders","role":"aut","given":"Anders"},{"given":"Nir","family":"Peled","display":"Peled, Nir","role":"aut"},{"family":"Demedts","role":"aut","display":"Demedts, Ingel","given":"Ingel"},{"given":"Elizabeth","family":"Dudnik","role":"aut","display":"Dudnik, Elizabeth"},{"role":"aut","display":"Eisert, Anna","family":"Eisert","given":"Anna"},{"display":"Hashemi, Sayed M. S.","role":"aut","family":"Hashemi","given":"Sayed M. S."},{"family":"Janzic","role":"aut","display":"Janzic, Urska","given":"Urska"},{"family":"Kian","display":"Kian, Waleed","role":"aut","given":"Waleed"},{"role":"aut","display":"Mohorcic, Katja","family":"Mohorcic","given":"Katja"},{"family":"Mohammed","display":"Mohammed, Saara","role":"aut","given":"Saara"},{"role":"aut","display":"Silvoniemi, Maria","family":"Silvoniemi","given":"Maria"},{"family":"Rothschild","display":"Rothschild, Sacha I.","role":"aut","given":"Sacha I."},{"given":"Christian","family":"Schulz","display":"Schulz, Christian","role":"aut"},{"family":"Wesseler","role":"aut","display":"Wesseler, Claas","given":"Claas"},{"given":"Alfredo","display":"Addeo, Alfredo","role":"aut","family":"Addeo"},{"given":"Karin","family":"Armster","display":"Armster, Karin","role":"aut"},{"role":"aut","display":"Itchins, Malinda","family":"Itchins","given":"Malinda"},{"given":"Marija","family":"Ivanović","display":"Ivanović, Marija","role":"aut"},{"given":"Diego","family":"Kauffmann-Guerrero","role":"aut","display":"Kauffmann-Guerrero, Diego"},{"given":"Jussi","family":"Koivunen","role":"aut","display":"Koivunen, Jussi"},{"family":"Kuon","display":"Kuon, Jonas","role":"aut","given":"Jonas"},{"display":"Pavlakis, Nick","role":"aut","family":"Pavlakis","given":"Nick"},{"family":"Piet","display":"Piet, Berber","role":"aut","given":"Berber"},{"role":"aut","display":"Sebastian, Martin","family":"Sebastian","given":"Martin"},{"given":"Janna-Lisa","family":"Velthaus-Rusik","display":"Velthaus-Rusik, Janna-Lisa","role":"aut"},{"family":"Wannesson","role":"aut","display":"Wannesson, Luciano","given":"Luciano"},{"display":"Wiesweg, Marcel","role":"aut","family":"Wiesweg","given":"Marcel"},{"family":"Wurm","role":"aut","display":"Wurm, Robert","given":"Robert"},{"given":"Corinna","family":"Albers-Leischner","role":"aut","display":"Albers-Leischner, Corinna"},{"given":"Daniela E.","family":"Aust","role":"aut","display":"Aust, Daniela E."},{"given":"Melanie","display":"Janning, Melanie","role":"aut","family":"Janning"},{"role":"aut","display":"Fabikan, Hannah","family":"Fabikan","given":"Hannah"},{"given":"Sylvia","family":"Herold","display":"Herold, Sylvia","role":"aut"},{"given":"Anna","role":"aut","display":"Klimova, Anna","family":"Klimova"},{"display":"Loges, Sonja","role":"aut","family":"Loges","given":"Sonja"},{"given":"Yana","family":"Sharapova","display":"Sharapova, Yana","role":"aut"},{"given":"Maret","role":"aut","display":"Schütz, Maret","family":"Schütz"},{"given":"Christoph","family":"Weinlinger","role":"aut","display":"Weinlinger, Christoph"},{"given":"Arschang","family":"Valipour","role":"aut","display":"Valipour, Arschang"},{"given":"Tobias","display":"Overbeck, Tobias","role":"aut","family":"Overbeck"},{"given":"Frank","display":"Griesinger, Frank","role":"aut","family":"Griesinger"},{"given":"Marko","display":"Jakopovic, Marko","role":"aut","family":"Jakopovic"},{"given":"Maximilian","display":"Hochmair, Maximilian","role":"aut","family":"Hochmair"},{"given":"Martin","role":"aut","display":"Wermke, Martin","family":"Wermke"}],"id":{"doi":["10.3390/ijms25073992"],"eki":["1906374899"]},"origin":[{"dateIssuedDisp":"April 2024","dateIssuedKey":"2024"}],"language":["eng"]} 
SRT |a ILLINIOLIVMOBOCERTIN2024 

Similar Items